From GLP-1 pricing to cash-pay care, the system is shifting toward a leaner, consumer-driven future — one that rewards those who rethink what insurance is for.
This week’s news and headlines unpacked, plus a Q&A with Rushika Fernandopulle
A recently-published analysis shows that provider pricing in the commercial market is essentially random, and there’s no correlation to quality
Practical solutions are coming and we explore 9 of them
"Tectonic Shifts" are happening as inflation, drug pricing battles, and cash-pay healthcare are colliding to redefine the industry’s next era.
I teamed up with two health policy experts to explore the bull and bear case.
